News

Press Release: Sanofi's SAR446523, A GPRC5D Monoclonal Antibody, Earns Orphan Drug Designation In The US For Multiple Myeloma
Sanofi's SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma <li /> Designation grante ...
Wegovy maker Novo’s profit warning wipes out $70B in market value after shares plunge 30%
Novo, which became Europe’s most valuable listed company following the launch of Wegovy in 2021, is now facing a reckoning as ...
PharmiWeb1h
Skeletal Dysplasia Market Growth, Analysis of Key Players, Trends, Drivers
Overview of Skeletal Dysplasia MarketThe Global Skeletal Dysplasia Market is valued at USD 3.42 Billion in 2024 and is ...
Wegovy maker Novo's profit warning triggers $70 billion share rout
COPENHAGEN (Reuters) -Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles ...